Tratamentul HTA in functie de prezenta altor modificari patologice

(dupa ESC 2007 guidelines for the management of arterial hypertension)

Clase preferate de anti-HTA
Leziuni ale organelor tinta datorate HTA
HVS (hipertrofie ventriculara stanga) IEC, AC, BRA
Ateroscleroza coronariana (asimptomatica) AC, IEC
Microalbuminurie IEC, BRA
Insuficienta renala IEC, BRA

Evenimente clinice
AVC in antecedente orice anti-HTA
IMA in antecedente BB, IEC, BRA
Angina pectorala BB, AC
IC cronica
Diuretice (de ansa / tiazidice + antialdosteronice),
BB, IEC, BRA
FIA recurenta BRA, IEC
FIA permanenta BB, AC (verapamil / diltiazem)
Proteinurie IEC, BRA, diuretice de ansa
Sdr. ischemie periferica AC
Sdr. metabolic IEC, BRA, diuretice
DZ diabet zaharat IEC, BRA
IEC inhibitori de enzima de conversie
AC antagonisti ai canalelor de calciu; DHP - dihidropiridine
BRA blocanti ai receptorilor ATII
BB beta-blocante

HTA in SARCINA AC (DHP - nifedipina), metildopa, BB (labetalol)